RxDoctor Payments Data

Meg Ellis

Medical · Johnson City, TNNPI 1083910384

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 572 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 51 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,192 and has fallen 65.2% since, to $764 in 2025. Among medical clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,407in general payments, 2019–2025

Across 572 payments — averaging $14.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • AstraZeneca$992
  • Lilly USA, LLC$578
  • Takeda Pharmaceuticals U.S.A., Inc.$429
  • Axsome Therapeutics, Inc.$416
  • plus $3K from 45 others

What the payments were for

  • Food & beverage$8,383100%
  • Education$240%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,407 in reported general payments places this provider in the 90th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban28$23,805
MounjaroTirzepatide14$14,631
EntrestoSacubitril/Valsartan13$8,071
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$7,701
SynthroidLevothyroxine Sodium34$2,959
ProgesteroneProgesterone, Micronized44$2,195
Estradiol (Twice Weekly)Estradiol12$1,446
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst40$996
Bupropion XlBupropion Hcl27$954
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen37$946
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen60$895
Nebivolol Hcl12$722
Gabapentin67$669
Potassium Chloride36$661
Irbesartan12$608

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$17$23,80528 claims
Lilly USA, LLCMounjaro$578$14,63114 claims
NovartisEntresto$192$8,07113 claims
AstraZenecaBreztri Aerosphere$992$7,70113 claims
AbbVieSynthroid$1,397$2,95934 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 480 medical providers in Tennessee.

Other medical in Johnson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →